CREATIVE REALITIES INC (CREX) Fundamental Analysis & Valuation

NASDAQ:CREX • US22530J3095

Current stock price

3.84 USD
+0.09 (+2.4%)
At close:
3.91 USD
+0.07 (+1.82%)
After Hours:

This CREX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CREX Profitability Analysis

1.1 Basic Checks

  • CREX had positive earnings in the past year.
  • CREX had a negative operating cash flow in the past year.
  • In multiple years CREX reported negative net income over the last 5 years.
  • In multiple years CREX reported negative operating cash flow during the last 5 years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

  • With a Return On Assets value of -14.93%, CREX is not doing good in the industry: 65.56% of the companies in the same industry are doing better.
  • CREX's Return On Equity of -41.80% is on the low side compared to the rest of the industry. CREX is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • With a Gross Margin value of 43.13%, CREX perfoms like the industry average, outperforming 54.44% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CREX has grown nicely.
  • CREX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CREX Health Analysis

2.1 Basic Checks

  • CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CREX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.40, we must say that CREX is in the distress zone and has some risk of bankruptcy.
  • CREX's Altman-Z score of 0.40 is on the low side compared to the rest of the industry. CREX is outperformed by 61.11% of its industry peers.
  • A Debt/Equity ratio of 1.01 is on the high side and indicates that CREX has dependencies on debt financing.
  • CREX has a Debt to Equity ratio of 1.01. This is comparable to the rest of the industry: CREX outperforms 48.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACCN/A
WACC8.67%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that CREX should not have too much problems paying its short term obligations.
  • CREX has a worse Current ratio (1.03) than 63.33% of its industry peers.
  • A Quick Ratio of 0.77 indicates that CREX may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.77, CREX is doing worse than 72.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CREX Growth Analysis

3.1 Past

  • CREX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 160.61%, which is quite impressive.
EPS 1Y (TTM)160.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%117.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • Based on estimates for the next years, CREX will show a very strong growth in Revenue. The Revenue will grow by 45.22% on average per year.
EPS Next Y30.05%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year83.66%
Revenue Next 2Y45.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

4

4. CREX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.20, which indicates a rather expensive current valuation of CREX.
  • Based on the Price/Earnings ratio, CREX is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
  • CREX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.87, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 14.76 indicates a correct valuation of CREX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CREX indicates a somewhat cheap valuation: CREX is cheaper than 64.44% of the companies listed in the same industry.
  • CREX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.51.
Industry RankSector Rank
PE 19.2
Fwd PE 14.76
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CREX indicates a slightly more expensive valuation: CREX is more expensive than 63.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 226.97
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CREX Dividend Analysis

5.1 Amount

  • No dividends for CREX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CREX Fundamentals: All Metrics, Ratios and Statistics

CREATIVE REALITIES INC

NASDAQ:CREX (4/17/2026, 8:03:50 PM)

After market: 3.91 +0.07 (+1.82%)

3.84

+0.09 (+2.4%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-14
Earnings (Next)05-12
Inst Owners10.26%
Inst Owner Change46.39%
Ins Owners5.61%
Ins Owner Change0%
Market Cap90.24M
Revenue(TTM)N/A
Net Income(TTM)-9.15M
Analysts84
Price Target8.29 (115.89%)
Short Float %0.48%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.19%
Min EPS beat(2)-149.99%
Max EPS beat(2)-82.4%
EPS beat(4)1
Avg EPS beat(4)57.24%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-6.96%
Max Revenue beat(2)6.23%
Revenue beat(4)2
Avg Revenue beat(4)-2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-2.2%
Revenue beat(12)4
Avg Revenue beat(12)-4.14%
Revenue beat(16)4
Avg Revenue beat(16)-3.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.2
Fwd PE 14.76
P/S 2.04
P/FCF N/A
P/OCF N/A
P/B 4.12
P/tB N/A
EV/EBITDA 226.97
EPS(TTM)0.2
EY5.21%
EPS(NY)0.26
Fwd EY6.77%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.89
BVpS0.93
TBVpS-0.85
PEG (NY)0.64
PEG (5Y)N/A
Graham Number2.04732 (-46.68%)
Profitability
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score2
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 46.08
Cap/Depr 51.44%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z 0.4
F-Score2
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)160.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y30.05%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%117.23%
Revenue Next Year83.66%
Revenue Next 2Y45.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-219.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.05%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-208.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.48%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 2 / 10 to CREX.


Can you provide the valuation status for CREATIVE REALITIES INC?

ChartMill assigns a valuation rating of 4 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


How profitable is CREATIVE REALITIES INC (CREX) stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to grow by 30.05% in the next year.